| Mr Christopher Thomas Boyer, DO | |
|
One Hospital Dr, Columbia, MO 65212 | |
| (573) 884-9066 | |
| (573) 884-3037 |
| Full Name | Mr Christopher Thomas Boyer |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | One Hospital Dr, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205109675 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital South | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Anthonys Physician Organization Hospitalist Services Lc | 5092980656 | 87 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Entity Name | Mercy Hospitals East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851431738 PECOS PAC ID: 1658276811 Enrollment ID: O20031218000107 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - St. Louis, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841235108 PECOS PAC ID: 6002809944 Enrollment ID: O20040406001004 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Entity Name | Mercy Clinic Adult Hospitalists - Washington, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891943429 PECOS PAC ID: 3577630540 Enrollment ID: O20080917000782 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Entity Name | St Anthonys Physician Organization Hospitalist Services Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407216336 PECOS PAC ID: 5092980656 Enrollment ID: O20111208000771 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Entity Name | Mercy Clinic Adult Hospitalists Jefferson Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083052492 PECOS PAC ID: 8628205598 Enrollment ID: O20131220001798 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Christopher Thomas Boyer, DO Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Mr Christopher Thomas Boyer, DO One Hospital Dr, Columbia, MO 65212 Ph: (573) 884-9066 |
News Archive
County- and municipality-level bans on tobacco sales to individuals under age 21 yield substantive reductions in smoking among 18- to 20-year-olds, according to a new study from the Yale School of Public Health.
A study presented at the ESMO Congress 2019 has revealed that a blood test may soon be able to pick up circulating tumor DNA to help avoid invasive tissue biopsies in lung cancer patients.
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Japanese researchers have developed and tested a prototype device - wearable on the fingertips - that incorporates the concept of 'light touch' to enhance the sense of balance. If widely implemented, the device should significantly reduce incidence of falls amongst seniors.
Researchers have identified four new regions on the human genome associated with Behcet's disease, a painful and potentially dangerous condition found predominantly in people with ancestors along the Silk Road.
› Verified 3 days ago
Aruna Cheddi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1600 E Broadway, Columbia, MO 65201 Phone: 573-815-8000 Fax: 573-815-8556 | |
Jason Shawn Ogden, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Dr. Peter James Nilsson, DO Hospitalist Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-884-9066 Fax: 573-884-3037 | |
Ethan Scott Anderson, DO Hospitalist Medicare: Medicare Enrolled Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-884-9066 Fax: 573-884-3037 | |
Dr. Monika Kulasekaran, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-884-7561 | |
Jyotsna Batapati Krishna Reddy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1600 East Broadway, Columbia, MO 65201 Phone: 573-815-8000 Fax: 573-815-6245 |